Blocking <scp>IL</scp>‐23 Signaling Mitigates Cigarette Smoke‐Induced Murine Emphysema
Inflammatory cell infiltration is a characteristic feature of COPD and correlates directly with the severity of the disease. Interleukin-23 (IL-23) is a pro-inflammatory cytokine that regulates Th-17 inflammation, which mediates many pathophysiological events in COPD. The primary goal of this study was to determine the role of IL-23 as a mediator of key pathologic processes in cigarette smoke-induced COPD. In this study, we report an increase in IL23 gene expression in the lung biopsies of COPD patients compared to controls and identified a positive correlation between IL23 gene expression and disease severity. In a cigarette smoke-induced murine emphysema model, the suppression of IL-23 with a monoclonal blocking antibody reduced the severity of cigarette smoke-induced murine emphysema. Mechanistically, the suppression of IL-23 was associated with a reduction in immune cell infiltration, oxidative stress injury, and apoptosis, suggesting a role for IL-23 as an essential immune mediator of the inflammatory processes in the pathogenesis of CS-induced emphysema.
Authors
- Chujie Zhang
- Robert Vassallo (ORCID: https://orcid.org/0000-0003-2328-0255)
- Y. S. Prakash (ORCID: https://orcid.org/0000-0002-2968-224X)
- Tian Xue (ORCID: https://orcid.org/0000-0001-6187-122X)
- Shaohua Wang (ORCID: https://orcid.org/0000-0002-8899-3160)
Institutions
- Mayo Clinic (US)
- Shanghai Jiao Tong University (CN)
- Shanghai First People's Hospital (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- Environmental Toxicology
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1002/tox.24405
- Citations
- 6
- Primary Topic
- Pediatric health and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 4.46
Funders
- Mayo Clinic
- Bristol-Myers Squibb
- Pfizer
- Sun Pharma
- National Institutes of Health